This Accessibility Statement outlines our commitment at Nuclear Medicines Australia to ensuring our website is accessible for all users, including those with disabilities. We are dedicated to providing a user-friendly experience and welcome feedback on how we can improve accessibility.
Accessibility Statement
This statement was last updated on 7 May 2026. We at Nuclear Medicines Australia are working to make our site accessible to all Australians seeking information on nuclear medicine.
What web accessibility is
Web accessibility ensures that individuals with disabilities can navigate and interact with our website as easily as those without disabilities. This includes support for various assistive technologies.
Accessibility adjustments on this site
We have adapted this site in accordance with WCAG 2.1 guidelines, achieving AA compliance. Our content is designed to work seamlessly with assistive technologies, including screen readers. Among our adjustments, we have:
Conducted regular accessibility audits to identify and rectify potential issues
Set the default language of the site
Optimized the content structure to enhance navigation
Implemented clear headings and labels throughout the site
Provided alternative text for all images
Ensured color contrast meets required standards
Minimized motion effects on the site
Made all multimedia content accessible
We acknowledge that certain third-party content may not fully comply with accessibility standards.
Some pages on our site include content from third-party sources. We are committed to addressing accessibility concerns on these pages as needed.
Accessibility arrangements in the organization
Our physical locations are equipped with accessible features, including designated parking spaces, ramps, elevators, and accessible restrooms to ensure all visitors can access our services comfortably.
Requests, issues, and suggestions
If you experience any accessibility barriers or have suggestions, please contact Nuclear Medicines Australia using the contact details provided on our website, and let us know the page address and the nature of the issue.